Italian medtech to gain through pharma decision?:
This article was originally published in Clinica
Executive Summary
The Italian health ministry is calling on the national pharmaceuticals market to cut the prices of medicines, citing evidence that they are "5% more expensive than the European average". The move is set to be welcomed by the rest of the healthcare industry, following high-profile calls for the standards of care to reflect the high cost of running the service (see Clinica No 969, p 7). In last week's correspondence with the pharmaceuticals industry association Farmindustria, health minister Girolamo Sirchia has stated his intention to adopt the "necessary measures" to correct the situation.